Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Clinical OutsourcingClinical Outsourcing
Not Confirmed
Not Confirmed
03-04 March, 2026
Natural Product Expo W...Natural Product Expo West
Not Confirmed
Not Confirmed
03-06 March, 2026
Natural Products ExpoNatural Products Expo
Not Confirmed
Not Confirmed
03-06 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Clinical OutsourcingClinical Outsourcing
Industry Trade Show
Not Confirmed
03-04 March, 2026
Natural Product Expo W...Natural Product Expo West
Industry Trade Show
Not Confirmed
03-06 March, 2026
Natural Products ExpoNatural Products Expo
Industry Trade Show
Not Confirmed
03-06 March, 2026
Digital content

24 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/24/3243761/0/en/Siren-Biotechnology-Receives-FDA-Fast-Track-Designation-for-SRN-101-for-the-Treatment-of-Recurrent-High-Grade-Glioma.html

28 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/28/3227916/0/en/Siren-Biotechnology-Announces-FDA-Clearance-of-First-IND-Advancing-Company-to-Clinical-Stage.html

07 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/07/3214573/0/en/Siren-Biotechnology-to-Showcase-Clinical-Stage-Momentum-at-Major-2026-Healthcare-Conferences.html

12 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/12/3079483/0/en/Siren-Biotechnology-to-Present-Universal-AAV-Immuno-Gene-Therapy-Data-at-the-2025-American-Society-of-Gene-and-Cell-Therapy-ASGCT-Annual-Meeting.html

05 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/05/3037647/0/en/Siren-Biotechnology-Expands-Clinical-and-Scientific-Advisory-Board-with-Key-Industry-Leaders.html

18 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/18/2982962/0/en/Siren-Biotechnology-Reveals-SRN-101-as-Lead-Asset-for-High-Grade-Gliomas-with-Both-Orphan-Drug-and-Rare-Pediatric-Disease-Designations-from-the-FDA.html
ABOUT THIS PAGE